- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/131 - Amines, e.g. amantadine acyclic
Patent holdings for IPC class A61K 31/131
Total number of patents in this class: 318
10-year publication summary
|
25
|
18
|
23
|
29
|
30
|
31
|
26
|
32
|
17
|
8
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Intellikine LLC | 41 |
7 |
| Acelot, Inc. | 16 |
6 |
| Duke University | 3191 |
5 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3324 |
5 |
| ThermoLife International, LLC | 187 |
5 |
| Advanced Biodesign | 17 |
4 |
| Institut Curie | 625 |
4 |
| University of Maryland, Baltimore | 1071 |
4 |
| Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. | 1359 |
4 |
| Allergan, Inc. | 2146 |
3 |
| Centre National de La Recherche Scientifique | 11122 |
3 |
| The Johns Hopkins University | 5948 |
3 |
| The Trustees of the University of Pennsylvania | 4441 |
3 |
| Aminex Therapeutics, Inc. | 10 |
3 |
| BioInteractions, Ltd. | 34 |
3 |
| Cedars-Sinai Medical Center | 1209 |
3 |
| Cornell University | 3458 |
3 |
| Dana-Farber Cancer Institute, Inc. | 2677 |
3 |
| Kinki University | 254 |
3 |
| NOVUS International, Inc. | 140 |
3 |
| Other owners | 241 |